Loading…
Enlivex Ltd. is projected to rise to $9.44 by 2027, a +38% move from its current price of $6.86. ENLV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.30 | $6.86 | $7.46 | -0.04% |
| Jul 14 | $6.08 | $6.85 | $7.73 | -0.09% |
| Jul 15 | $5.91 | $6.85 | $7.94 | -0.13% |
| Jul 16 | $5.78 | $6.85 | $8.12 | -0.18% |
| Jul 17 | $5.66 | $6.84 | $8.28 | -0.22% |
| Jul 18 | $5.56 | $6.84 | $8.42 | -0.27% |
| Jul 19 | $5.46 | $6.84 | $8.56 | -0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.46 | $6.84 | $8.56 | -0.31% |
| Week 2 | $4.96 | $6.82 | $9.37 | -0.62% |
| Week 3 | $4.61 | $6.80 | $10.03 | -0.93% |
| Week 4 | $4.32 | $6.77 | $10.62 | -1.24% |
| Week 5 | $4.09 | $6.75 | $11.16 | -1.55% |
| Week 6 | $3.88 | $6.73 | $11.67 | -1.86% |
| Week 7 | $3.70 | $6.71 | $12.16 | -2.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis.
The company develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2.
Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Enlivex Ltd. is currently priced at $6.86 with a market capitalization of $115.47M. It holds a rank of 4115 among listed assets.
The overall price outlook, according to the forecast, shows a path of higher levels after 2026, with 2027 average price of $9.44 and bullish sentiment, followed by 2028 average $8.97 and 2029 average $8.84, continuing to 2030 with an average of $8.63.
From 2033 onward the forecast includes a bullish trajectory, with 2033 average $9.75 and 2034 average $12.94, 2035 average $12.66, and 2040 average $16.26. The 2050 forecast shows an average of $23.28, indicating long-term upside potential.
A major floor 93.0% below — a decisive break under it would weaken the trend.
The nearest floor, 93.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 62.0% above — clearing it would confirm fresh momentum.
Key ENLV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENLV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.77 | Buy | $2.63 | Buy |
| MA 10 | $1.17 | Buy | $1.69 | Buy |
| MA 20 | $0.9064 | Buy | $1.19 | Buy |
| MA 50 | $0.8241 | Buy | $0.9372 | Buy |
| MA 100 | $0.9224 | Buy | $0.9181 | Buy |
| MA 200 | $0.9622 | Buy | $0.9669 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 97.05 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 666.67 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.40 | Buy |
| ROC (12) | 1001.12 | Buy |
| Bollinger %B (20,2) | 1.59 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.59 | Buy |
| Awesome (5,34) | 0.93 | Buy |
| Ultimate (7,14,28) | 97.55 | Sell |
| Momentum (10) | 6.26 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 2.38 | Buy |
| ADX (14) | 39.22 | Buy |
| ATR (14) | 0.47 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 100, signaling a strong momentum reading. The simple moving averages are SMA50 at $0.8241 and SMA200 at $0.9622, with a defined resistance at $6.86 and a support level at $0.481.
The 30-day range spans $3.92 to $12.01, highlighting notable near-term volatility around the current price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.481 | $6.86 | $9.57 | 0% | Neutral | |
| $6.85 | $9.44 | $14.07 | +38% | Bullish | |
| $6.13 | $8.97 | $14.25 | +31% | Bullish | |
| $5.73 | $8.84 | $14.74 | +29% | Bullish | |
| $5.34 | $8.63 | $14.99 | +26% | Bullish | |
| $4.72 | $7.98 | $14.33 | +16% | Neutral | |
| $4.49 | $7.92 | $14.67 | +15% | Neutral | |
| $5.31 | $9.75 | $18.56 | +42% | Bullish | |
| $6.77 | $12.94 | $25.25 | +89% | Bullish | |
| $6.37 | $12.66 | $25.29 | +85% | Bullish | |
| $7.32 | $16.26 | $35.70 | +137% | Bullish | |
| $10.48 | $23.28 | $53.54 | +239% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.481 | $6.86 | $8.49 | +0.00% |
| August 2026 | $5.40 | $6.54 | $8.25 | -4.68% |
| September 2026 | $5.36 | $6.59 | $8.49 | +0.72% |
| October 2026 | $5.80 | $7.22 | $9.46 | +9.60% |
| November 2026 | $5.83 | $7.33 | $9.75 | +1.56% |
| December 2026 | $5.59 | $7.10 | $9.57 | -3.18% |
Click any year to see its month-by-month ENLV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ENLV could reach as high as $9.57, with a base case around $6.86 and support toward $0.481 — roughly 0% from $6.86. Price action looks broadly range-bound.
Expect ENLV to range from $6.85 to $14.07 through 2027. The $9.44 average target implies a +38% move from current prices. That is up +38% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ENLV price prediction for 2028 points to an average of $8.97 (low $6.13, high $14.25) — a potential gain of +31% on today's $6.86. Momentum favours further upside here.
In 2029, ENLV is projected to trade between $5.73 and $14.74, averaging $8.84 — a potential gain of +29% from today's $6.86. That is -1% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Enlivex Ltd.'s 2030 outlook centres on $8.63, within a $5.34 to $14.99 range. That is -2% versus the projected 2029 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2031, ENLV could reach as high as $14.33, with a base case around $7.98 and support toward $4.72 — roughly +16% from $6.86. A consolidation phase looks the most probable path here.
Expect ENLV to range from $4.49 to $14.67 through 2032. The $7.92 average target implies a +15% move from current prices. That is -1% versus the projected 2031 average. Price action looks broadly range-bound.
The ENLV price prediction for 2033 points to an average of $9.75 (low $5.31, high $18.56) — a potential gain of +42% on today's $6.86. Buyers look set to stay in control over this stretch.
In 2034, ENLV is projected to trade between $6.77 and $25.25, averaging $12.94 — a potential gain of +89% from today's $6.86. That is up +33% on the projected 2033 average. Momentum favours further upside here.
Enlivex Ltd.'s 2035 outlook centres on $12.66, within a $6.37 to $25.29 range. That is -2% versus the projected 2034 average. That marks a +85% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ENLV could reach as high as $35.70, with a base case around $16.26 and support toward $7.32 — roughly +137% from $6.86. Momentum favours further upside here.
Expect ENLV to range from $10.48 to $53.54 through 2050. The $23.28 average target implies a +239% move from current prices. That is up +43% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENLV today (≈ 145.772595 ENLV) could be worth
$3,393.57
+$2,393.57 (+239%) by 2050 · US Dollar
Based on the average projected ENLV price of $23.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENLVwould be worth at today's price.
$1,000 invested in ENLV on Jul 10, 2025 (≈ 746.268638 ENLV) would be worth
$5,119.4
+$4,119.4 (+411.9%) today · 5.12× · US Dollar
Based on a ENLV entry price of $1.34 vs. today's $6.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.5276 | $13,002.27 | +1200.2% |
| 1 month ago | $0.673 | $10,193.17 | +919.3% |
| 3 months ago | $0.962 | $7,130.98 | +613.1% |
| 6 months ago | $0.953 | $7,198.32 | +619.8% |
| 1 year ago | $1.34 | $5,119.4 | +411.9% |
| All time (5.0y) ago | $8.05 | $852.17 | -14.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENLV forecast.
Our base-case forecast reaches $14.00 around 2040.
Implied market cap at $14.00: $235.65M
The multi-year forecast points to a bullish path in several years, with 2027 at an average of $9.44 and a 37.6% ROI, and 2028 at an average of $8.97 with a 30.8% ROI. 2029 shows an average of $8.84 and a 28.9% ROI, and 2030 an average of $8.63 with a 25.9% ROI, all labeled as BULLISH or NEUTRAL as indicated.
In 2031 and 2032 the outlook is NEUTRAL, with average prices of $7.98 and $7.92 respectively, and lower ROIs of 16.3% and 15.4%.
2033 is BULLISH with an average of $9.75 and a 42.1% ROI, 2034 shows a steep rise to an average of $12.94 and an 88.6% ROI, and 2035 at $12.66 with an 84.5% ROI. The forecast continues BULLISH into 2040 with an average of $16.26 and a 137.1% ROI, and 2050 at an average of $23.28 with a 239.4% ROI. These are estimates and not guarantees, reflecting potential upside and associated risks.
Tap a question to reveal the answer.
Year 2030 forecast: avg $8.63, min $5.34, max $14.99, ROI 25.9%, sentiment BULLISH.
Forecast shows bullish sentiment in 2027-2030 and 2033-2050 with multiple annual averages and ROIs (e.g., 2027 avg $9.44, ROI 37.6%; 2034 avg $12.94, ROI 88.6%), though 2026 is neutral and these are estimates, not guarantees.
Yes. The 2034 forecast shows max $25.25, with an average of $12.94 and ROI 88.6%, sentiment BULLISH.
Current price is $6.86 and market cap is $115.47M.
The 2050 forecast shows min $10.48, avg $23.28, max $53.54, ROI 239.4%, sentiment BULLISH.
Enlivex Ltd. Community Discussion
0Share your Enlivex Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.